Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambrisentan (GSK1325760) Phase 2 Trial in Japan
jRCT2080221388Phase 2Completed
- Start
- Feb 2011
- Modality
- Small Molecules
01
Overview
Phase 2 trial of ambrisentan in cardiac morbidity. Started Feb 2011; status: completed.
02
Drugs
ambrisentan
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on jRCT2080221388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221388.